Photo of H. Morgan Griffith
R United States House · District 9 · Virginia On the 2026 ballot

Rep. H. Morgan Griffith

Compare
Total votes
2,818
all sessions
Attendance
97%
92 missed
Near the chamber average
With party
91%
of cast votes
Near the chamber average
Bipartisan score
5%
crosses aisle rarely
Near the chamber average
Sponsored
504
bills & resolutions
Lower than 87% of chamber peers
Committees
7
assignments
504 bills and resolutions

Sponsored bills

Total
504
Primary
93
Co-sponsor
411
This page
504
matching current filters
Co-sponsor HR 888
In committee · Washington House · Co-sponsor
RIDE Act of 2021

Reinforcing Impaired Driving Education Act of 2021 or the RIDE Act of 2021 This bill requires the National Highway Traffic Safety Administration to establish a two-year pilot program to create and study the effects of a public marketing campaign to raise awareness on driving while under the influence of prescription and over-the-counter medications. The program shall be implemented in states or territories that are most affected by the opioid epidemic.

In committee Feb 8, 2021 1 co-sponsor
Co-sponsor HR 841
In committee · Washington House · Co-sponsor
Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 This bill allows the use of hemp, cannabidiol (i.e., CBD) derived from hemp, or any other ingredient derived from hemp in a dietary supplement, provided that the supplement meets other applicable requirements. (Currently, the Food and Drug Administration's position is that CBD products may not be sold as dietary supplements.)

In committee Feb 5, 2021 1 co-sponsor
Co-sponsor HR 747
In committee · Washington House · Co-sponsor
Access to TESTs Act

Access to Technology and Equipment for Same-day Tests Act or the Access to TESTs Act This bill establishes grant programs to increase access to diagnostic tests. Specifically, the Centers for Disease Control and Prevention (CDC) must award grants to hospitals, primary care facilities, and other health care providers to buy equipment and supplies to increase access to same-day diagnostic testing in point-of-care settings. The CDC must also award grants to public health and other laboratories to buy high-throughput diagnostic equipment and supplies to increase testing capacity and expedite test results.

In committee Feb 4, 2021 1 co-sponsor
Co-sponsor HRES 61
In committee · Washington House · Co-sponsor
Expressing the sense of the House of Representatives that Medicare and Social Security provide an essential benefit for current enrollees and should be strengthened for future generations.

This resolution affirms the House of Representatives' obligation to fulfill the promises made to senior citizens of the United States regarding access to Medicare and Social Security. It also rejects any changes to Medicare or Social Security that diminish benefits for Americans currently enrolled, or soon to be enrolled, in the Medicare program or the Old Age, Survivors, and Disability Insurance program. The resolution also expresses the House's commitment that these programs should be strengthened and preserved, and expresses support for efforts to reduce waste, fraud, and abuse in these programs.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 682
In committee · Washington House · Co-sponsor
Reopen Schools Act

Reopen Schools Act This bill requires a local educational agency (LEA) to reopen its elementary and secondary schools as a condition for receiving certain supplemental education emergency relief funding. Specifically, an LEA must provide in-person instruction to at least 50% of its students in order to receive the full funding. An LEA that provides in-person instruction to at least some of its students shall have its funding reduced on a pro rata basis.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 541
In committee · Washington House · Co-sponsor
Defund Planned Parenthood Act of 2021

Defund Planned Parenthood Act of 2021 This bill restricts federal funding for Planned Parenthood Federation of America Inc. or any of its affiliates or clinics for one year. Specifically, it prohibits funding those entities unless they certify that the affiliates and clinics will not perform, and will not provide funds to entities that perform, abortions during that year. If the certification requirement is not met, the Department of Health and Human Services and the Department of Agriculture must recoup any federal assistance received by those entities. However, the bill's funding restriction does not apply to abortions performed in cases of rape or incest or when necessary to resolve a physical condition that endangers a woman's life. The bill also provides additional funding for community health centers for the one-year period. These funds are subject to the same abortion-related restrictions and exceptions.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 554
In committee · Washington House · Co-sponsor
SAVE Moms and Babies Act of 2021

Support And Value Expectant Moms and Babies Act of 2021 or the SAVE Moms and Babies Act of 2021 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner to also act as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 471
In committee · Washington House · Co-sponsor
PAUSE Act of 2021

Protecting Americans from Unnecessary Spread upon Entry from COVID-19 Act of 2021 or the PAUSE Act of 2021 This bill maintains immigration restrictions put in place under public health emergency authorities to prevent the introduction of COVID-19 (i.e., coronavirus disease 2019) from foreign countries. Specifically, the bill prohibits the Department of Health and Human Services from rescinding or reducing the stringency of the restrictions. It also prohibits the Department of Homeland Security from stopping or reducing enforcement of the restrictions. These prohibitions remain in effect until (1) federal and state COVID-19 emergency orders are lifted, and (2) the risk of introducing COVID-19 in or from Canada and Mexico is minimal.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 432
In committee · Washington House · Co-sponsor
Mental Health Access Improvement Act of 2021

Mental Health Access Improvement Act of 2021 This bill provides for coverage of marriage and family therapist services and mental health counselor services under Medicare. It also excludes such services from the skilled nursing facility prospective payment system, and authorizes marriage and family therapists and mental health counselors to develop discharge plans for post-hospital services.

In committee Feb 2, 2021 1 co-sponsor
Primary HR 245
In committee · Washington House · Lead sponsor
New Source Review Permitting Improvement Act

New Source Review Permitting Improvement Act This bill modifies terminology for purposes of the New Source Review (NSR) permitting program of the Environmental Protection Agency (EPA). In order for a change to a stationary source to be a modification (a change to a stationary source that increases the air pollutant emissions or results in new pollutants) for purposes of the NSR permitting program, the maximum hourly emission rate achievable by such source must be higher than the maximum hourly rate achievable by such source during any hour in the 10-year period preceding the change. A change at a stationary source is not considered to be a modification under the bill if it is designed to (1) reduce the amount of any air pollutant emitted; or (2) restore, maintain, or improve the reliability of operations at, or safety of, the source. However, such changes are not excepted if the EPA determines the increase in the maximum achievable hourly emission rate from such change would cause an adverse effect on human health or the environment. Construction , in connection with a major emitting facility (a type of stationary source), does not include a change at such a facility that does not result in a significant emissions increase or a significant net emissions increase. In relation to major emitting facilities in nonattainment areas, the terms modifications and modified do not include changes at such facilities that do not result in a significant emissions increase or a significant net emissions increase.

In committee Feb 2, 2021 0 co-sponsors
Showing 491 to 500 of 504 bills